Bio Rad Laboratories IncNYSE:BIO.B
- LAST PRICE279.9100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 279.9100
- Day Range---
- 52 Week Range
- Volume5
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Yesterday
Bio-Rad Announces Life Science Group Management Changes, from 8:30AM ET on Friday Apr 26, 2024 by Dow Jones
8:30AM ET on Friday Apr 26, 2024 by Dow Jones
Apr 18, 2024
Press Release: Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:06AM ET on Thursday Apr 18, 2024 by Dow Jones
9:06AM ET on Thursday Apr 18, 2024 by Dow JonesBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024, from 9:00AM ET on Thursday Apr 18, 2024 by Dow Jones
9:00AM ET on Thursday Apr 18, 2024 by Dow Jones
Apr 11, 2024
DJ Oncocyte, Bio-Rad Partner on Global Launch of Transplant Assay, from 6:11PM ET on Thursday Apr 11, 2024 by Dow Jones
6:11PM ET on Thursday Apr 11, 2024 by Dow JonesOncocyte and Bio-Rad Partner on Global Launch of Transplant Assay, from 5:30PM ET on Thursday Apr 11, 2024 by Dow Jones
5:30PM ET on Thursday Apr 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bio Rad Laboratories Inc | 9.3B | 0.0x | --- |
Company Information
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Contact Information
- Headquarters
- 1000 ALFRED NOBEL DRHERCULES, CA, United States 94547-1811
- Phone
- 510-724-7000
- Fax
- 510-741-5817
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.3B |
|---|---|
Revenue (TTM) | $2.7B |
Shares Outstanding | 33.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.92 |
EPS | $-21.49 |
Book Value | $306.51 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 12.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
